|
|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$6,614,862
|
N/A
|
National Cancer Institute
|
|
|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
2R01CA173481-06
|
$385,883
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
$496,135
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112-10339
|
$292,456
|
$14,622
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
Using Email to Enhance Counseling Services at NCI's Smoking Cessation Quitline
|
5K07CA124579-04
|
$134,528
|
$134,528
|
ABROMS, LORIEN
|
GEORGE WASHINGTON UNIVERSITY
|
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer
|
1R01CA213996-01A1
|
$343,125
|
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
|
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
|
5K08CA218420-02
|
$177,120
|
|
AGUIRRE, ANDREW
|
DANA-FARBER CANCER INST
|
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
5R01CA218024-02
|
$428,136
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
Mutagenesis and migration in glioblastoma cells
|
1R21CA220111-01A1
|
$179,240
|
|
AHN, EUN HYUN
|
UNIVERSITY OF WASHINGTON
|
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Post-translational control of cancer cell stress response and metastasis
|
5R01CA202027-03
|
$459,505
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-08
|
$216,434
|
$12,986
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
SIGNALING MECHANISMS IN REGULATION OF TUMOR ANGIOGENESIS
|
5R01CA143128-02
|
$264,476
|
$264,476
|
Akulapalli, Sudhakar
|
FATHER FLANAGAN'S BOYS' HOME
|
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$797,394
|
$79,739
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$828,679
|
$82,867
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S1
|
$139,575
|
$22,332
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S2
|
$75,000
|
$12,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-33
|
$3,953,813
|
$632,610
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-02S1
|
$45,000
|
$6,750
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-02
|
$779,584
|
$116,938
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Lymphatic and systemic immunity changes in post-radiation lymphedema development
|
5R01CA201487-03
|
$357,343
|
|
ALDRICH, MELISSA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
|
Profiling signaling activity and gene expression in single, pancreatic adenocarcinoma cells using CE-RNA-Seq
|
1R01CA224763-01A1
|
$575,272
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-04
|
$362,569
|
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-04
|
$741,952
|
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,066,163
|
$10,661
|
Alter, Blanche
|
DCEG (NCI)
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-42S1
|
$125,781
|
$8,805
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-09
|
$1,222,825
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-42
|
$2,401,347
|
$168,094
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-04
|
$340,960
|
$57,963
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Lung cancer heterogeneity and its impact on drug resistance.
|
5R01CA133253-02
|
$453,272
|
$453,272
|
ALTSCHULER, STEVEN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
5R01CA178610-05
|
$317,240
|
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
5R01CA208042-03
|
$363,713
|
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
5U01CA151452-02
|
$413,032
|
$206,516
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
5U19CA148127-02
|
$2,612,327
|
$2,612,327
|
AMOS, CHRISTOPHER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-05
|
$307,736
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of Splicing Factors in Breast Cancer
|
5R00CA178206-05
|
$249,000
|
|
ANCZUKOW-CAMARDA, OLGA
|
JACKSON LABORATORY
|
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
|
Molecular Mechanisms of EGF Signaling & Iressa/Tarceva Inhibition in NSCLC
|
5R01CA127580-04
|
$314,248
|
$314,248
|
ANDERSON, KAREN
|
YALE UNIVERSITY
|
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-02
|
$323,594
|
$64,719
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
|
Performance, safety, and efficacy of a new cyrotherapy device for cervical dyspla
|
5UH3CA189923-05
|
$762,683
|
|
ANDERSON, JEAN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
|
5F31CA221012-02
|
$30,434
|
|
ANDREWS, JARED
|
WASHINGTON UNIVERSITY
|
|
Total relevant funding to Lung for this search: $343,364,000
|
